Agape ATP Corporation Common Stock (ATPC) had the highest return between October 10, 2019 and November 1, 2019 by a US stock, returning 550%.
| ASSET | DATE | % RETURN |
|---|---|---|
Agape ATP Corporation Common Stock (ATPC) | 10/10/2019 - 11/1/2019 | 550% |
N2OFF (NITO) | 10/10/2019 - 11/1/2019 | 231.11% |
Datasea (DTSS) | 10/10/2019 - 11/1/2019 | 215.28% |
Xunlei Ltd Adr (XNET) | 10/10/2019 - 11/1/2019 | 180.36% |
Relmada Therapeutics (RLMD) | 10/10/2019 - 11/1/2019 | 166.67% |
Oncolytics Biotech (ONCY) | 10/10/2019 - 11/1/2019 | 121.15% |
Oxbridge Re Holdings Equity Warrant (OXBRW) | 10/10/2019 - 11/1/2019 | 118.13% |
Assembly Biosciences (ASMB) | 10/10/2019 - 11/1/2019 | 100.83% |
Castellum (CTM) | 10/10/2019 - 11/1/2019 | 82% |
Portage Biotech (PRTG) | 10/10/2019 - 11/1/2019 | 78.57% |
Nutex Health (NUTX) | 10/10/2019 - 11/1/2019 | 74.4% |
Clearside Biomedical (CLSD) | 10/10/2019 - 11/1/2019 | 72.04% |
GlucoTrack (GCTK) | 10/10/2019 - 11/1/2019 | 66.67% |
Nutriband (NTRB) | 10/10/2019 - 11/1/2019 | 66.67% |
Aclaris Therapeutics (ACRS) | 10/10/2019 - 11/1/2019 | 64.35% |
Avinger (AVGR) | 10/10/2019 - 11/1/2019 | 63.77% |
BeOne Medicines (ONC) | 10/10/2019 - 11/1/2019 | 62.87% |
Arbutus Biopharma (ABUS) | 10/10/2019 - 11/1/2019 | 62.57% |
Nocera (NCRA) | 10/10/2019 - 11/1/2019 | 62.5% |
Applied Therapeutics (APLT) | 10/10/2019 - 11/1/2019 | 61.14% |
Cardiff Oncology (CRDF) | 10/10/2019 - 11/1/2019 | 59.29% |
Aspira Womens Health (AWH) | 10/10/2019 - 11/1/2019 | 58.18% |
Reliance Global (RELI) | 10/10/2019 - 11/1/2019 | 54.03% |
Adverum Biotechnologies (ADVM) | 10/10/2019 - 11/1/2019 | 53.29% |
DiaMedica Therapeutics (DMAC) | 10/10/2019 - 11/1/2019 | 53.19% |
